Adaptive Biotechnologies ... (ADPT)
NASDAQ: ADPT
· Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT
Adaptive Biotechnologies Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 43.16M | 50.65M | 47.92M | 38.08M | 59.82M | 71.23M | 65.06M | 88.71M | 109.24M | 94.61M | 90.03M | 217.55M | 76.41M | 114.81M | 139.06M | 122.4M | 184.19M | 173.62M |
Short-Term Investments | 154.71M | 142.78M | 174.37M | 205.25M | 232.06M | 237.64M | 281.34M | 282.42M | 307.99M | 346.08M | 408.17M | 290.53M | 307.33M | 248.76M | 214M | 292.64M | 414.23M | 540.64M |
Long-Term Investments | 24.1M | 39.35M | 33.66M | 23.87M | 2.98M | 2.96M | 2.93M | 2.92M | 2.92M | n/a | 2.4M | 19.7M | 66.93M | 137.11M | 217.15M | 217.38M | 91.13M | 30.69M |
Other Long-Term Assets | 4.73M | 4.6M | 5.18M | 5.63M | 3.15M | 6.35M | -1.54M | 5.9M | 6.28M | 4.5M | 4.46M | 4.63M | 3.22M | 3.26M | 3.01M | 3.01M | 2.86M | 2.85M |
Receivables | 44.28M | 43.58M | 41.73M | 40.81M | 35.61M | 42.02M | 37.97M | 31.21M | 31.55M | 30.97M | 40.06M | 26.55M | 23.71M | 22.52M | 17.41M | 17.12M | 14.17M | 19.75M |
Inventory | 8.4M | 8.68M | 8.44M | 11.96M | 13.21M | 13.29M | 14.45M | 19.49M | 18.96M | 19.87M | 14.45M | 17.34M | 18.78M | 21M | 19.26M | 18.23M | 18.61M | 17.42M |
Other Current Assets | 11.29M | 10.8M | 11.29M | 12.25M | 10.85M | 1.1M | 11.37M | 13.4M | 9.07M | n/a | 9.44M | 1M | 800K | 1.1M | 1.4M | 2.1M | 2.5M | 3.3M |
Total Current Assets | 261.86M | 256.49M | 283.75M | 308.35M | 351.55M | 374.03M | 410.19M | 435.24M | 476.81M | 501.33M | 562.15M | 564.38M | 438.57M | 419.12M | 402.75M | 467.03M | 643.73M | 764.96M |
Property-Plant & Equipment | 84.39M | 88.43M | 94.38M | 97.84M | 103.94M | 116.26M | 120.32M | 152.01M | 156.5M | 160.25M | 164.21M | 169.27M | 171.25M | 171.63M | 172.94M | 177.27M | 167.3M | 144.81M |
Goodwill & Intangibles | 121.56M | 121.98M | 122.4M | 122.83M | 123.25M | 123.68M | 124.1M | 124.53M | 124.96M | 125.38M | 125.8M | 126.23M | 126.66M | 127.08M | 127.5M | 127.93M | 128.35M | 128.78M |
Total Long-Term Assets | 234.78M | 254.36M | 255.62M | 250.16M | 233.32M | 246.29M | 250.95M | 282.44M | 287.73M | 290.13M | 294.47M | 319.83M | 368.06M | 439.07M | 520.6M | 525.58M | 389.64M | 307.13M |
Total Assets | 496.64M | 510.85M | 539.38M | 558.51M | 584.87M | 620.32M | 661.13M | 717.68M | 764.54M | 791.46M | 856.62M | 884.21M | 806.63M | 858.19M | 923.34M | 992.61M | 1.03B | 1.07B |
Account Payables | 6.91M | 6.36M | 7.26M | 7.35M | 9.87M | 12.17M | 7.72M | 4.48M | 9.16M | 6.33M | 8.08M | 4.16M | 2.72M | 5.96M | 3.31M | 8.25M | 6.09M | 5.2M |
Deferred Revenue | 55.3M | 54.8M | 55.69M | 51.86M | 52.23M | 46.87M | 48.63M | 55.34M | 57.92M | 60.32M | 64.11M | 67.89M | 80.91M | 83.5M | 80.46M | 79.95M | 83.55M | 78.35M |
Short-Term Debt | n/a | n/a | n/a | n/a | 9.81M | n/a | 9.38M | 3.19M | 9.35M | n/a | n/a | 8.53M | 8.62M | 8.54M | n/a | 5.11M | 4.83M | 4.31M |
Other Current Liabilities | 12.77M | 26.64M | 26.94M | 12.34M | -287K | 7.91M | 4.3M | 10.15M | 1.21M | 6.12M | 12.42M | 4.21M | 1.16M | 1.86M | 9.34M | 11.93M | 8.71M | 9.18M |
Total Current Liabilities | 92.14M | 87.81M | 98.05M | 87.63M | 88.13M | 82.95M | 88.02M | 93.3M | 95.33M | 90.1M | 109.79M | 104.02M | 111.47M | 115.07M | 113.81M | 122.38M | 116.65M | 106.77M |
Long-Term Debt | n/a | 131.55M | 132.41M | n/a | 132.08M | n/a | 130.66M | n/a | n/a | n/a | 125.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 130.51M | 232.82M | 132.43M | 165.5M | 20K | 131.54M | n/a | 126.73M | 128.17M | 127.01M | n/a | 124.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 224.96M | 232.82M | 238.84M | 247.31M | 255.32M | 262.61M | 264.84M | 262.75M | 273.24M | 277.41M | 282.73M | 292.38M | 176.85M | 189.87M | 205.44M | 218.68M | 223.42M | 239.61M |
Total Liabilities | 317.1M | 320.63M | 336.89M | 334.93M | 343.44M | 345.56M | 352.86M | 356.05M | 368.57M | 367.51M | 392.52M | 396.39M | 288.32M | 304.94M | 319.24M | 341.06M | 340.06M | 346.38M |
Total Debt | 84.37M | 86.9M | 89.39M | 91.83M | 226.26M | 96.49M | 229.43M | 101.31M | 103.52M | 105.78M | 108M | 109.05M | 111.34M | 113.52M | 111.74M | 113.15M | 108.61M | 99.56M |
Common Stock | 15K | 15K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K |
Retained Earnings | -1.36B | -1.33B | -1.3B | -1.27B | -1.24B | -1.19B | -1.14B | -1.07B | -1.02B | -976.78M | -919.08M | -878.95M | -833.67M | -781.63M | -718.89M | -657.46M | -601.55M | -552.25M |
Comprehensive Income | 73K | n/a | 166K | n/a | -182K | -106K | 215K | -250K | -893K | -1.91M | -4.12M | -5.97M | -5.8M | -4.78M | -1.14M | 7K | 216K | 631K |
Shareholders Equity | 179.72M | 190.42M | 202.71M | 223.77M | 241.6M | 274.91M | 308.4M | 361.73M | 396.04M | 424.02M | 464.17M | 487.84M | 518.3M | 553.21M | 603.99M | 651.51M | 693.18M | 725.59M |
Total Investments | 178.81M | 182.13M | 208.03M | 229.11M | 235.03M | 237.64M | 284.27M | 282.42M | 307.99M | 346.08M | 408.17M | 310.23M | 374.25M | 385.87M | 431.14M | 510.02M | 505.36M | 571.33M |